189 results on '"Malley, Richard"'
Search Results
2. Safety, tolerability and immunogenicity of a novel 24-valent pneumococcal vaccine in toddlers: A phase 1 randomized controlled trial
3. Immunization with a whole cell vaccine reduces pneumococcal nasopharyngeal density and shedding, and middle ear infection in mice
4. Corticosteroids and Other Treatments Administered to Children Tested for SARS-CoV-2 Infection in Emergency Departments
5. Optimization of Expression and Purification of Schistosoma mansoni Antigens in Fusion with Rhizavidin
6. Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.
7. Vaccination for healthy aging.
8. Generation of protective pneumococcal-specific nasal resident memory CD4+ T cells via parenteral immunization
9. CD4 + T Cells Mediate Antibody-Independent Acquired Immunity to Pneumococcal Colonization
10. Recognition of Pneumolysin by Toll-like Receptor 4 Confers Resistance to Pneumococcal Infection
11. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine
12. Recombinant BCG expressing a PspA-PdT fusion protein protects mice against pneumococcal lethal challenge in a prime-boost strategy
13. IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine
14. Meningococcal Disease among Children Who Live in a Large Metropolitan Area, 1981-1996
15. Induction of Broad Immunity against Invasive Salmonella Disease by a Quadrivalent Combination Salmonella MAPS Vaccine Targeting Salmonella Enterica Serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A.
16. A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults
17. Impact of SARS-CoV-2 Infection on the Association Between Laboratory Tests and Severe Outcomes Among Hospitalized Children.
18. Introduction of New Journal Section—Translational Medicine
19. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability
20. Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity
21. Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity
22. B cell–intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice
23. Low Risk of Bacterial Meningitis in Children with a Positive Enteroviral Polymerase Chain Reaction Test Result
24. The Pneumococcal Pilus Predicts the Absence of Staphylococcus aureus Co-Colonization in Pneumococcal Carriers
25. Does Pneumococcal Conjugate Vaccine Influence Staphylococcus aureus Carriage in Children?
26. Epidemiologic Evidence for Serotype-Specific Acquired Immunity to Pneumococcal Carriage
27. Serotype replacement in disease after pneumococcal vaccination
28. Serum Antipneumococcal Antibodies and Pneumococcal Colonization in Adults with Chronic Obstructive Pulmonary Disease
29. Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines.
30. A Bivalent MAPS Vaccine Induces Protective Antibody Responses against Salmonella Typhi and Paratyphi A.
31. Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein
32. Anticapsular Polysaccharide Antibodies and Nasopharyngeal Colonization with Streptococcus pneumoniae in Infant Rats
33. Minimum Protective Serum Concentrations of Pneumococcal Anti-Capsular Antibodies in Infant Rats
34. Preclinical Immunogenicity and Efficacy of a Multiple Antigen-Presenting System (MAPS TM) SARS-CoV-2 Vaccine.
35. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis
36. SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model
37. Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae
38. CD[4.sup.+] T cells mediate antibody-independent acquired immunity to pneumococcal colonization
39. Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.
40. Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era
41. Meta-analysis of bacterial meningitis score validation studies
42. Risk factors for cerebral edema in children with diabetic ketoacidosis
43. Children with Bacterial Meningitis Presenting to the Emergency Department during the Pneumococcal Conjugate Vaccine Era
44. Clinical Prediction Rule for Identifying Children With Cerebrospinal Fluid Pleocytosis at Very Low Risk of Bacterial Meningitis
45. Evaluation of the febrile child 3 to 36 months old in the era of pneumococcal conjugate vaccine: focus on occult bacteremia
46. Antibody Seronegativity in COVID-19 RT-PCR–Positive Children.
47. Robust Immune Response Induced by Schistosoma mansoni TSP-2 Antigen Coupled to Bacterial Outer Membrane Vesicles.
48. A new prognostic scoring system for meningococcal septic shock in children: comparison with three other scoring systems
49. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
50. Antibiotic Treatment of Children With Unsuspected Meningococcal Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.